Thomas Strack

Thomas Strack

Directeur Technique/Scientifique/R&D chez VTV THERAPEUTICS INC.
Health Technology
Consumer Services
Commercial Services

Profil

Thomas Strack currently works at vTv Therapeutics, Inc., as Chief Medical Officer from 2023.
Dr. Strack also formerly worked at Pfizer Inc., as Medical Director from 2000 to 2008, Eli Lilly & Co., as Senior Scientist from 1993 to 2000, Progenics Pharmaceuticals, Inc., as Vice President-Clinical Development from 2015 to 2018, Takeda Global Research & Development Center, Inc., as Vice President-Metabolic Diseases from 2009 to 2012, Asubio Pharmaceutical, Inc., as Head-Research & Development from 2012 to 2015, Molecular Templates, Inc., as Senior Vice President-Clinical Development from 2019 to 2022, and Faeth Therapeutics, Inc., as Chief Medical Officer.
Dr. Strack received his doctorate degree from The Johannes Gutenberg University of Mainz.

Postes actifs de Thomas Strack

SociétésPosteDébut
VTV THERAPEUTICS INC. Directeur Technique/Scientifique/R&D 02/11/2023

Anciens postes connus de Thomas Strack

SociétésPosteFin
MOLECULAR TEMPLATES, INC. Directeur Technique/Scientifique/R&D 01/01/2022
PROGENICS PHARMACEUTICALS, INC. Directeur Technique/Scientifique/R&D 01/01/2018
Directeur Technique/Scientifique/R&D 01/01/2015
Takeda Global Research & Development Center, Inc.
Corporate Officer/Principal 01/01/2012
PFIZER INC. Directeur Technique/Scientifique/R&D 01/01/2008
Voir l'expérience en détail de Thomas Strack

Formation de Thomas Strack

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

85

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Health Technology

Consumer Services

Takeda Global Research & Development Center, Inc.

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Bourse
  2. Insiders
  3. Thomas Strack
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT